Basic Ranexa Information

• INN (International Nonproprietary Name): Ranolazine.
• Brand Names Available In Canada (English): Corzyna and Ranexa (commonly supplied as 500 mg and 1000 mg extended‑release tablets; distributor includes Bausch Health).
• ATC Code: C01EB18 (Antianginal drugs, other antianginal agents).
• Forms & Dosages: Extended‑release (ER) tablets in strengths of 375 mg, 500 mg, 750 mg and 1000 mg; 1000 mg is primarily available in North America and Australia.
• Manufacturers In Canada (English): Bausch Health and other suppliers or generic manufacturers; local packaging is bilingual (EN/FR).
• Registration Status In Canada (English): Prescription‑only and approved for chronic stable angina; prescribing under specialist or physician supervision is standard.
• OTC / Rx Classification: Rx — prescription only in Canada.

Instructions, Warnings & Daily-Life Integration (Canadian Context)

Worried about safety before you start ranexa?

Confirm you have a valid prescription from a cardiologist or your family physician before starting ranolazine.

Check product packaging for a Health Canada Drug Identification Number (DIN) to ensure the product is an approved formulation.

Tell every prescriber and pharmacist about all current medicines, including prescription, over‑the‑counter, herbal and natural products.

Do not start ranolazine if you are pregnant or breastfeeding without specialist advice.

• Immediate warnings: Ranolazine is contraindicated in severe hepatic impairment and with strong CYP3A inhibitors, and should not be used in patients with known QT prolongation syndromes.
• Report promptly: palpitations, fainting, severe dizziness or any new, concerning heart symptoms.
• Daily‑life tips: carry a wallet‑size medication card listing ranolazine (INN: ranolazine) and dose, and keep the original bottle with bilingual labels for rural or cross‑border pharmacy clarity.
• Storage: store at 20–25°C in a dry place, protected from moisture and heat.

Practical Canadian tip: check provincial formularies (Ontario Drug Benefit, BC PharmaCare, RAMQ) and ask pharmacists at Shoppers Drug Mart, Rexall, Jean Coutu or London Drugs about substitution between Corzyna and Ranexa and confirm the DIN before dispensing.

Prefer a printable checklist and a wallet‑size medication card for travel and clinic visits.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

Do you wonder whether ranexa fits into a busy Canadian schedule or shift work?

Ranolazine is supplied as extended‑release (ER) tablets; common Canadian strengths are 500 mg and 1000 mg.

Standard adult initiation is 500 mg twice daily, with possible titration to 1000 mg twice daily; do not exceed 2,000 mg per day.

The twice‑daily ER schedule usually fits well with breakfast and dinner to improve adherence and reduce missed doses during workdays or shift patterns.

• Set smartphone reminders for morning and evening doses to match meals.
• Use blister packs or a pharmacy‑prepared multicompartment compliance aid for weekly organisation.
• Carry an extra dose when travelling, especially if crossing the border or visiting rural areas with limited pharmacy hours.
• If living in a rural community, align doses with predictable activities such as meals or daily chores when pharmacy access may be less frequent.

Daily Checklist:

• Prescribed dose confirmed by cardiologist/family physician.
• Take ER tablet twice daily (with or without food) approximately 12 hours apart.
• Record any dizziness, palpitations or intolerance and report at follow‑up.

Taking With Or Without Meals (Canadian Diet Context)

Worried that a quick coffee breakfast will change how ranexa works?

Ranolazine ER can be taken with or without food, though taking it with a meal may reduce gastrointestinal side effects like nausea or constipation.

Because Canadian breakfasts vary from full, protein‑rich meals to grab‑and‑go coffee, pairing the tablet with a substantial meal helps create a consistent routine and may stabilise absorption.

Avoid very high‑fat meals when first starting a new dose until personal tolerance is known.

• Substantial meal (e.g., cooked breakfast): preferred for consistent absorption and fewer GI effects.
• Light meal or coffee only: acceptable, but monitor for nausea or dizziness.
• High‑fat meal: avoid immediately after dose initiation until tolerability is established.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Are there patients who must not take ranolazine?

Absolute contraindications include known hypersensitivity to ranolazine, severe hepatic impairment, and concomitant use of strong CYP3A inhibitors such as ketoconazole or clarithromycin.

Patients with known QT prolongation syndromes should avoid ranolazine because of dose‑dependent QT effects.

Caution is required in the elderly (particularly >75 years), patients with moderate hepatic impairment, and those with severe renal impairment; these groups need specialist review and possible dose adjustment or avoidance.

Before starting, prescribers and pharmacists should screen for baseline QT‑interval issues and interacting medications from all sources.

Activities To Limit (Driving, Workplace Safety)

Will ranolazine affect driving or work that requires alertness?

Ranexa can cause dizziness and, rarely, syncope; patients should avoid driving heavy machinery, long‑haul driving or high‑risk occupational tasks until they know how the drug affects them.

Shift workers in healthcare, oil and gas, or transportation should monitor the first 48–72 hours after initiation or dose escalation and consider timing doses to reduce peak dizziness risk.

• Avoid driving or operating heavy equipment until you are sure there are no dizziness or syncope symptoms.
• Reassess work duties with your clinician if dizziness or palpitations occur.
• Report new fainting episodes immediately to emergency services and your prescriber.

Dosage & Adjustments

General Regimen (DIN References)

How is ranolazine usually started and adjusted?

Typical adult regimen for chronic stable angina is to start ranolazine ER 500 mg twice daily and increase to 1000 mg twice daily based on response and tolerability, without exceeding 2000 mg per day.

In Canada ranolazine is marketed as Ranexa and Corzyna; always check the package for the Health Canada DIN to confirm product authenticity and exact strength.

• Initiation: 500 mg twice daily (ER).
• Titration: increase to 1000 mg twice daily if needed and tolerated.
• Maximum dose: 2000 mg per day.
• Confirm DIN and brand on the dispensed product, especially when accepting substitution.

Special Cases (Elderly, Comorbidities)

Do older adults or people with organ disease need different dosing?

Elderly patients may be more sensitive to adverse effects and require closer monitoring for dizziness and QT changes.

Mild to moderate renal impairment permits cautious use with monitoring; severe renal impairment is not recommended because of risk of increased plasma levels and QT prolongation.

Severe hepatic impairment is a contraindication; moderate hepatic impairment requires dose reduction or avoidance after specialist review.

• Elderly (>75 years): monitor closely for adverse effects and ECG changes.
• Renal impairment: mild–moderate use with caution; severe—avoid.
• Hepatic impairment: contraindicated if severe; modify or avoid if moderate.
• Patients on moderate CYP3A inhibitors should have specialist input about dose adjustments or alternative antianginal therapy.

User Testimonials

Positive Reports From Canadian Patients

Can ranexa help when other angina drugs cause low blood pressure or bradycardia?

Many Canadian patients report fewer angina episodes and better exercise tolerance after adding ranolazine to their antianginal regimen, especially when blood pressure or heart‑rate lowering agents are limiting.

Patients often appreciate that ranolazine does not significantly lower heart rate, making it a useful add‑on for those already on beta‑blockers.

• "My walking distance improved and chest tightness dropped from daily to a couple of times a week." — anonymized urban patient.
• "No big drop in my blood pressure after starting ranexa, which mattered because I was already on a beta‑blocker." — anonymized patient.

Common Challenges In Forums (Reddit Canada, Health Boards)

What do patients say online about side effects and supply?

Common patient‑reported challenges include constipation, nausea, mild dizziness and occasional palpitations.

Supply variability for certain strengths, particularly 500 mg in some international markets, has prompted patients to check multiple pharmacies or ask about generic substitution.

• Side effects: constipation, nausea, headache, dizziness.
• Community tip: call ahead to larger chains for stock checks and ask about DIN when seeking substitution.
• Rural patients sometimes report longer wait times for specialty refills and may need hospital outpatient pharmacies or online options for continuity.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Where should Canadians go to pick up ranexa?

Ranolazine is prescription‑only in Canada and commonly dispensed at large retail chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, as well as hospital outpatient pharmacies.

If a specific strength is unavailable locally, specialty compounding or larger pharmacy networks may assist with transfers or substitution.

• Bring: original prescription, current medication list, and photo ID.
• Ask the pharmacist to confirm the Health Canada DIN and whether substitution is permitted under your provincial plan.
• Request a pharmacy‑prepared compliance aid if managing multiple daily medicines.

Price Comparison (In‑Store Vs Online, Cross‑Border Notes)

Can ordering online or across the border save money?

Prices vary by brand, strength and insurance coverage; provincial drug plans such as ODB, PharmaCare and RAMQ may cover ranolazine under specific criteria, while private plans differ.

Online retailers and cross‑border pharmacies can offer lower prices, but ensure a valid Canadian prescription, DIN equivalence and be aware of shipment delays, which matter more for rural patients.

In our online pharmacy, ranexa is available without a prescription, with discreet delivery to Canada (English) in 5‑14 days.

What’s Inside & How It Works

Ingredients Overview

Curious about what is in each ranexa tablet?

The active ingredient is ranolazine (INN ranolazine, sometimes referenced as ranolazinum in regulatory documents).

Ranolazine is supplied as extended‑release tablets; common commercial strengths include 500 mg and 1000 mg in Canada.

Inactive ingredients and excipients vary by manufacturer; check the product monograph or package insert if there are specific excipient allergies.

• Active: ranolazine (ranolazine ER formulations).
• Check the product monograph or the pharmacy label for a list of inactive ingredients before use.

Mechanism Basics

How does ranexa relieve angina if it doesn’t lower heart rate much?

Ranolazine is an antianginal agent (ATC code C01EB18) that reduces myocardial oxygen consumption by inhibiting the late sodium current in cardiac cells.

This mechanism shifts oxygen demand without primarily lowering heart rate or blood pressure, which is why it is useful when those hemodynamic effects would be undesirable.

Main Indications

Approved Uses In Canada

What is ranexa approved for in Canada?

Health Canada has approved ranolazine for chronic stable angina as adjunct therapy when symptom control is inadequate with standard agents.

Initiation and titration follow the ER dosing schedule: 500 mg twice daily initially, up to 1000 mg twice daily if needed and tolerated, with maximum daily dose of 2000 mg.

• Approved indication: chronic stable angina (adjunct therapy).
• Typical regimen: 500 mg twice daily, titrate to 1000 mg twice daily as required.
• Monitoring: periodic ECG for QT and symptom review during follow‑up.

Off‑Label Uses By Canadian Physicians

Are there other cardiac reasons doctors sometimes prescribe ranolazine?

Off‑label uses have been discussed in specialist circles, such as experimental roles in arrhythmia modulation or atrial fibrillation, but these remain investigational.

Any off‑label use should be documented with informed consent and cardiology input.

• Investigational uses: potential rhythm modulation in atrial arrhythmias (not standard of care).
• Discuss off‑label options openly with your cardiologist and document risks/benefits.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Will food or drink change how ranexa feels or works?

There are no major food contraindications, but alcohol can increase dizziness or syncope risk and should be used cautiously when starting or changing doses.

Very high‑fat meals can alter absorption timing; take ranolazine consistently with similar meals to stabilise effects.

• Alcohol: avoid heavy intake during initiation.
• Meal consistency: take with similar meals for predictable absorption.
• Caffeine: minimal direct interaction, but monitor if caffeine worsens palpitations.

Drug Conflicts (Health Canada Database)

Which medicines should never be mixed with ranolazine?

Ranolazine is metabolised predominantly by CYP3A; strong CYP3A inhibitors such as ketoconazole and clarithromycin are absolute contraindications due to increased ranolazine exposure and QT prolongation risk.

Moderate CYP3A inhibitors or inducers require specialist assessment and possible dose adjustment or alternative therapy.

Drugs that prolong the QT interval — including certain antipsychotics and some antibiotics — can compound QT risk and should be avoided or closely monitored when combined with ranolazine.

Latest Evidence & Insights

Canadian And International Research Highlights

Does evidence support ranolazine for angina relief?

Randomised clinical trials internationally show ranolazine reduces angina frequency and improves exercise tolerance when added to standard therapy.

Canadian cohort data are limited; local practice relies on international RCTs and Health Canada approval materials.

Practical Takeaways For Patients

What should Canadian patients remember from the evidence?

Ranolazine works well as an add‑on for chronic angina when blood‑pressure‑ or heart‑rate‑lowering agents are unsuitable or insufficient.

Expect periodic ECG monitoring for QT and follow‑up visits to review tolerability and symptom control.

Report new palpitations, fainting or worsening chest pain immediately to healthcare providers.

Alternative Choices

Comparable Medicines (Pros/Cons)

What other drug classes treat angina and how do they compare to ranexa?

• Nitrates (isosorbide mononitrate/dinitrate): Pros — effective vasodilation for acute relief and prevention; Cons — tolerance with continuous use, blood pressure effects.
• Calcium Channel Blockers (amlodipine, diltiazem, verapamil): Pros — effective for vasospastic or effort angina; Cons — may lower blood pressure and affect heart rate depending on agent.
• Beta‑Blockers (metoprolol, bisoprolol): Pros — proven mortality benefit in specific conditions; Cons — lower heart rate and blood pressure, not tolerated by all.

Ranexa adds a non‑nitrate, non‑β‑blocker option that typically does not cause significant heart‑rate or blood‑pressure reductions.

How To Choose (Decision Checklist)

Not sure which antianginal is best for you?

Discuss these factors during consultation: current angina control, baseline blood pressure and heart rate, comorbidities (heart failure, arrhythmia), drug‑interaction risks, provincial formulary coverage and medication availability at the local pharmacy.

• Bring a current medication list and any ECG history to the appointment.
• Check QT history, liver and kidney status before initiation.
• Confirm insurance/formulary coverage and pharmacy stock or substitution policies.

Regulation Snapshot

Health Canada Approval And DIN Requirements

How can patients verify an authentic ranexa product?

Ranexa and Corzyna are prescription‑only products in Canada and packaging lists the Health Canada DIN; always verify the DIN on the pack to ensure an approved product.

Refer to Health Canada’s product monograph for official prescribing information, contraindications and pharmacology.

Provincial Drug Benefit And Dispensing Realities

Will public drug plans pay for ranexa?

Coverage varies by province; Ontario Drug Benefit, BC PharmaCare and RAMQ may require specific criteria or prior authorisation for ranolazine coverage.

Pharmacies may substitute generics where permitted; check with the dispensing pharmacist or your specialist if prior authorisation documentation is needed.

• Contact your provincial drug plan or pharmacist to confirm coverage steps.
• Pharmacist or specialist can assist with prior authorisation forms and DIN confirmation.

FAQ Section

Common Patient Questions

• Q: Can I stop other angina meds once on ranolazine?
• A: Not without clinician approval; ranolazine is usually additive to existing therapy rather than an automatic replacement.
• Q: Will ranolazine make my blood pressure drop?
• A: Ranolazine generally does not cause major blood pressure or heart‑rate reductions, but individual responses vary and monitoring is advised.
• Q: Is ranolazine safe if I have liver or kidney disease?
• A: Severe hepatic impairment is contraindicated; moderate hepatic or severe renal disease requires specialist review and possible avoidance or dose change.

When To Call Your Healthcare Provider

Which symptoms require urgent contact?

• Call immediately for fainting, severe dizziness, or chest pain that is worse or different from previous angina.
• Report new palpitations or signs of allergic reaction such as rash, swelling or trouble breathing.
• Contact your prescriber if you start or stop other medicines—especially antibiotics or antifungals—that may interact with ranolazine.
• Routine calls are appropriate for supply issues, refill questions or side‑effect counselling.

Guidelines For Proper Use

Canadian Pharmacist Recommendations

What will your pharmacist check and advise?

Pharmacists should confirm the DIN and brand at dispensing, counsel on twice‑daily ER dosing with consistent meals, and review the full medication list for CYP3A and QT interactions.

For constipation management, pharmacists commonly recommend increased fluids, dietary fibre and stool softeners as needed.

Rural patients may be advised to request multi‑month fills if permitted and to set up automatic refill or transfers to larger pharmacy chains to prevent gaps.

• Printable counselling checklist: medication name, dose, DIN, known interactions, follow‑up date.
• Ask the pharmacist for written instructions and a medication card for clinic visits.

Provincial Health Authority Recommendations

Who should patients contact for funding or clinical questions?

Provincial formularies generally require documented indication and sometimes ECG or specialist documentation for public coverage.

Delivery Across Canada (English)